Frankfurt - Delayed Quote EUR
Medpace Holdings, Inc. (01P.F)
258.30
-7.20
(-2.71%)
As of 6:00:01 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,156,580
2,109,054
1,885,842
1,459,996
1,142,377
Cost of Revenue
1,477,067
1,452,749
1,361,337
1,027,558
814,222
Gross Profit
679,513
656,305
524,505
432,438
328,155
Operating Expense
223,189
209,435
187,680
153,741
129,540
Operating Income
456,324
446,870
336,825
278,697
198,615
Net Non Operating Interest Income Expense
27,339
24,996
-488
-2,905
-105
Other Income Expense
-2,353
4,056
-655
7,068
3,342
Pretax Income
481,310
475,922
335,682
282,860
201,852
Tax Provision
64,920
71,536
52,872
37,492
20,004
Net Income Common Stockholders
416,391
404,342
282,619
245,211
181,390
Diluted NI Available to Com Stockholders
416,391
404,342
282,619
245,211
181,390
Basic EPS
13.51
--
9.20
7.57
5.06
Diluted EPS
13.10
--
8.88
7.28
4.81
Basic Average Shares
30,843
--
30,722
32,388
35,862
Diluted Average Shares
31,812.75
--
31,841
33,671
37,697
Total Operating Income as Reported
456,324
446,870
336,825
278,697
198,615
Total Expenses
1,700,256
1,662,184
1,549,017
1,181,299
943,762
Net Income from Continuing & Discontinued Operation
416,390
404,386
282,810
245,368
181,848
Normalized Income
416,819.10
404,807.60
284,434.22
242,022.25
179,344.12
Net Interest Income
27,339
24,996
-488
-2,905
-105
EBIT
456,324
446,870
336,825
278,697
198,615
EBITDA
485,513
476,121
363,153
301,038
219,734
Reconciled Cost of Revenue
1,477,067
1,452,749
1,361,337
1,027,558
814,222
Reconciled Depreciation
29,189
29,251
26,328
22,341
21,119
Net Income from Continuing Operation Net Minority Interest
416,390
404,386
282,810
245,368
181,848
Total Unusual Items Excluding Goodwill
-496
-496
-1,929
3,859
2,779
Total Unusual Items
-496
-496
-1,929
3,859
2,779
Normalized EBITDA
486,009
476,617
365,082
297,179
216,955
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-66.90
-74.40
-304.78
513.25
275.12
12/31/2021 - 8/15/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ILU.MU Illumina Inc
67.64
-0.60%
300347.SZ Hangzhou Tigermed Consulting Co., Ltd
45.05
-0.97%
IJF.MU Icon PLC
128.05
+2.56%
603127.SS Joinn Laboratories(China)Co.,Ltd.
15.54
+0.65%
EZB.F Enzo Biochem, Inc.
0.4240
+19.77%
0RUG.IL bioMérieux S.A.
115.70
+1.58%
SLV.WA Selvita S.A.
33.00
+2.17%
TN8.DE Thermo Fisher Scientific Inc.
372.95
+0.11%
ILU.F Illumina, Inc.
68.11
+0.58%
IJF.F ICON Public Limited Company
125.55
-1.65%